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INTRODUCTION
DA-8159, a selective phosphodiesterase type 5 (PDE5)
inhibitor developed by DongA Pharmaceutical Company
(Kyunggi, Korea), is an oral agent for treating erectile dys-
function. DA-8159 induces penile erection dose-dependently
in both anesthetized and conscious animals. It also induces
smooth muscle relaxation and increases the endogenous cyclic
guanosine monophosphate (cGMP) level in the rabbit corpus
cavernosal smooth muscles (1). The data obtained from phase
1 clinical study showed DA-8159 is safe and well tolerated
after a single oral dose in healthy males up to 300 mg with-
out severe adverse effects (unpublished data). However, as with
other PDE5 inhibitors, it may inhibit phosphodiesterase type
6 (PDE6) at a higher concentration. The inhibitory concen-
tration of DA-8159 on the PDE6 receptor is 10 times higher
than that of the PDE5 receptor.
PDE5 is present in human platelets and vascular smooth
muscles. PDE5 inhibition causes a vascular dilatation by block-
ing cGMP hydrolysis in the vascular smooth muscle. PDE6
is present in retinal photoreceptor cells, and is essential for
visual excitation, named phototransduction. The visual exci-
tation begins with the absorption of a photon of light by the
pigment rhodopsin. In this process, PDE6 hydrolyzes cGMP
to guanosine monophosphate (GMP), resulting in a decrease
in the intracellular cGMP levels. This light-dependent de-
crease in cGMP leads to hyperpolarization of the photorecep-
tors through the closure of cation channels. The inhibition of
PDE6 increases the intracellular concentration of cGMP, which
leads to opening of the sodium channels resulting in depolar-
ization of the photoreceptor cells. The alteration of sodium
channels causes exchange of Ca++, Na+ and Mg++ through the
photoreceptor cells. As a result, ionic conductance generates
an electrical response, which is transmitted to the visual cortex
of the brain and produces a visual sensation. The visual exci-
tation process can be recorded using electroretinography. If
DA-8159 acts as a PDE6 inhibitor in retinal photoreceptor
cells and inhibits the phototransduction process, an electrical
alternation should be recorded in an electroretinogram (ERG).
Sildenafil citrate (Viagra
�, Pfizer, Inc., New York, NY,
U.S.A.) was initially developed as a drug to treat angina, but
it was found to be highly specific to PDE5. Recently, it has
been widely used to treat patients with erectile dysfunction.
However, variable systemic and ocular side effects have been
reported. The ocular side effects include visual halo (2), third
nerve palsy (3), nonarteritic anterior ischemic optic neuritis
(4, 5), etc. As observed with sildenafil, DA-8159 may cause
such ocular side effects. Theoretically, PDE inhibitor may
change the retinal physiology in two ways; an alteration of the
phototransduction process by PDE6 inhibition at the photore-
ceptor cells, and an alteration in vascular flow by PDE5 inhi-
bition at the vascular smooth muscle. We have previously
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Effect of DA-8159, a Selective Phosphodiesterase Type 5 Inhibitor,
on Electroretinogram and Retinal Histology in Rabbits
DA-8159, a selective inhibitor of phosphodiesterase type 5, was developed as a new
drug for erectile dysfunction. The effect of DA-8159 on the electroretinogram (ERG)
and the retinal histopathology were evaluated in rabbits. The ERG was performed
prior to, and 1 and 5 hr after DA-8159 (5 to 30 mg/kg) administration. The plasma
concentration of DA-8159 was determined at each time point, and retinal microscopic
examination was also performed. There was no statistically significant ERG change
at any dose or at any time. Though the 30 Hz flicker showed a prolongation of the
implicit time at 5 hr after the administration of either DA-8159 15 mg or 30 mg/kg
(p<0.05), but concurrent amplitude decreases were not statistically significant. At a
dose of 5 mg/kg, no test drug was detected in the blood after either 1 or 5 hr. At either
15 mg/kg or 30 mg/kg, there was a dose-dependent increase in the blood concen-
tration after 1 hr of drug administration, which decreased with time. In light and elec-
tron microscopic examinations of the retina, there was no remarkable change at any
dose. These results suggest DA-8159 has a low risk potential to the retina, but fur-
ther evaluation on the visual functions in human is needed.
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been able to assess the alteration of phototransduction by
ERG or the subjective visual symptoms, and the alteration
of the blood flow by Doppler flowmetry (6-8). 
The objectives of this animal experiment were to investigate
the effects of DA-8159 on the ERGs, and to examine the his-
tological change after DA-8159 administration in rabbits.
MATERIALS AND METHODS
Twenty male rabbits (1.5 to 2.0 kg of body weight, bw) were
used for the electroretinography and blood concentration mea-
surements. The rabbits were divided into four groups; the DA-
8159 5 mg/kg, 15 mg/kg, and 30 mg/kg bw treated groups
and a control group. The test drug, DA-8159, was dissolved
in 5 mL of saline and fed through an L-tube. The control rab-
bits were given equal amount of saline. Each group consist-
ed of five rabbits. 
To evaluate the ERG changes after DA-8159 administra-
tion, electroretinography was performed prior to administra-
tion, one hour after, and five hours after the drug administra-
tion. To analyze the relationship between the blood concen-
trations of DA-8159 and the ERG changes, 5 mL of blood
was drawn from the ear vein prior to and immediately after
the ERG recording. The eyeball was enucleated immediately
after electroretinography for the histological examination. 
For electroretinography, the rabbits were kept in the dark
for twenty minutes for adaptation. The pupil was dilated
with an eyedrop of 2.5% phenylephrine hydrochloride. The
animal was anesthetized with an intramuscular injection of
ketamine hydrochloride (65 mg/kg bw) and xylazine hydro-
chloride (15 mg/kg bw) mixture. The recording electrodes
were placed on both corneas. The ERG jet (Universo SA,
Switzerland) was used as the recording electrode. The refer-
ence electrode was placed centrally on the shaven forehead.
For the stability of the electrode, one end of a reference elec-
trode was replaced by a skin needle, and was inserted into
the forehead skin. The ground electrode was placed on the
earlobe. Corneal dehydration was prevented by the frequent
application of hydroxy-propyl-methylcellulose. The ERG was
recorded using a UTAS-E 2000 system (LKC Technologies,
Inc, Gaithersburg, Maryland, U.S.A.). The light stimuli were
generated by a Ganzfeld dome stimulator (LKC Technologies).
Full-field electroretinography was performed according to
the Standard for Clinical electroretinography recommended
by the International Society for Clinical Electrophysiology
of Vision (ISCEV) (9). As recommended by the ISCEV, five
basic responses were obtained from each rabbit. The signifi-
cance of the ERG changes after drug administration was ana-
lyzed using a Bonferroni test. In brief, the time-dependent
ERG changes according to the drug concentrations were com-
pared with that of the control group. The relationship between
the blood concentration of DA-8159 and the ERG changes
were analyzed using linear regression analysis.
For histological examination, the eyeball was enucleated
1 or 5 hr after the drug administration. The eyeball was enu-
cleated under general anesthesia with an intramuscular injec-
tion of ketamine hydrochloride and xylazine hydrochloride
mixture. A total of twenty rabbits, two rabbits in each group,
were used for the histological examination. After enucleation,
the animal was sacrificed by ketamine overdose. Immediate-
ly after enucleation, the eyeball was immersed in a fixative
solution of 2% glutaraldehyde in 0.1 M phosphate buffers.
One eye from each rabbit was used for optical microscopic
examinations, and the other was used for electron microscop-
ic examinations. For the optical microscopic examination,
the eyeball was placed in 20 mL of 10% formaldehyde for
24 hr. For electron microscopic examination, the eyeball was
bisected and a tissue block was cut into a 2×3 mm size using
an dissecting microscope. The block was placed in 2% glu-
taraldehyde in 0.1 M phosphate buffer for 90 min in the cold,
and post-fixed in 1% osmium tetraoxide for 90 min. After
fixation, the block was dehydrated serially with ethanol, and
embedded in epon. A semi-thin section was stained with
uranyl acetate and lead citrate. The ultrastructural study was
performed by transmission electron microscopy (ISI-LEM
2000, Akashi, Japan).
RESULTS
The five standard electroretinographic responses obtained
from DA-8159 administrated and the saline ingested group
are shown in Table 1. In the rod response, there was no remark-
able ERG change at any dose or at any time after DA-8159
administration. In the maximal response, a statistically sig-
nificant decrease in the b-wave amplitude (p<0.05) was noted
at 5 hr after the administration of DA-8159 30 mg/kg, with-
out a concurrent implicit time change. Otherwise no remark-
able ERG changes were observed in the wave implicit time
or amplitude at any dose or at any time after the test drug
administration. The oscillatory potentials showed no signif-
icant change. In the cone response, there was no ERG change
at any dose or at any time after the test drug administration.
The 30-Hz flicker responses showed a statistically significant
prolongation in the implicit time (p<0.05) after 5 hr of DA-
8159 15 mg/kg or 30 mg/kg bw administration. The changes
were associated with a concurrent decrease in the amplitude,
even though this was statistically not significant (p>0.05). 
The dose-dependent blood concentrations of DA-8159 as
a function of time are shown in Table 2. No test drug was
detected in the blood after 1 or 5 hr at dose of DA-8159 5
mg/kg bw. At doses of 15 mg/kg and 30 mg/kg bw, there
was a dose-dependent increase of the blood concentration after
1 hr of drug administration. However, no difference in the
blood concentration was found after 5 hr. There was no corre-
lation between the blood concentration and the ERG change
after 1 or 5 hr of test drug administration. 588 H.K. Cho, K.K. Kang, G.J. Ahn, et al.
Dose
(mg/kg)
Time afterDA-8159 administration
Baseline 1 hr 5 hr 1 5
Time-dependent difference
No.
Rod b-wave Saline 10 52±13 47±10 57±9.8 -5 4.9
response implicit 5 10 43±5.1 50±8.4 54±7.2 7.4 10.9
time (msec) 15 10 57±6.6 58±6.3 57±14 1.2 0.3
30 10 60±6.1 52±3.7 64±3.7 -7.7 3.9
b-wave Saline 10 18±8.5 17±9.2 24±12 -0.8 6.5
amplitude 5 10 10±3.4 18±8.9 27±19 8.0 17.3
( volt) 15 10 28±11 38±12 34±12 10.7 6.8
30 10 35±14 47±147 57±20 12.2 22.5
Maximum a-wave Saline 10 15±1.7 14±2.1 14±0.7 -0.5 4.9
response implicit 5 10 13±1.9 13±0.8 14±1.4 -0.2 11.2
time (msec) 15 10 13±0.6 13±0.9 14±1.0 -0.3 0.4
30 10 14±0.8 13±0.8 14±0.8 -0.8 -0.3
a-wave Saline 10 46±27 44±26 51±23 -1.8 5.7
amplitude 5 10 29±6.5 37±1.0 33±8.4 7.9 4.2
( volt) 15 10 43±14 48±14 32±8.3 4.6 -10.7
30 10 58±14 58±19 41±18 0.4 -17.0
b-wave Saline 10 42±2.1 44±2.1 41±3.3 1.2 -1.9
implicit 5 10 36±3.4 36±2.3 39±5.3 -0.4 2.5
time (msec) 15 10 37±1.0 37±1.1 40±1.3 0.6 3.9
30 10 38±1.7 37±1.6 38±3.8 -0.9 -0.3
b-wave Saline 10 131±9 142±33 134±36 10.8 3.0
amplitude 5 10 100±43 116±38 130±404 16.1 30.1
( volt) 15 10 147±31 152±29 138±28 5.6 -9.1
30 10 191±63 171±48 147±56 -20.3 -43.8 
Oscillatory Saline 10 77±19 83±20 93±30 6.3 16.6
potentials 5 10 91±25 131±39 156±42 39.4 65.0
( volt) 15 10 110±21 107±21 81±19 -3.1 -28.8
30 10 92±20 99±18 78±20 7.2 -13.2
Cone a-wave Saline 10 13±3.7 13±3.4 14±1.0 0.5 1.1
response implicit 5 10 13±2.9 11±3.3 12±1.3 -1.3 -1.0
time 15 10 12±1.4 13±1.0 14±1.1 0.8 1.5
(msec) 30 10 13±1.0 12±1.8 12±2.3 -0.9 -0.6
a-wave Saline 10 9.8±4.3 12±2.2 14±5.7 2.5 4.1
amplitude 5 10 12±4.2 14±4.3 16±7.1 1.4 3.5
( volt) 15 10 8±2.7 13±5.2 7.6±5.8 4.7 -0.4
30 10 12±4.1 14±4.6 7.6±4.2 2.5 -3.9
b-wave Saline 10 35±1.7 36±1.8 33±1.3 1.4 -1.5
implicit 5 10 33±5.9 31±1.9 33±1.4 -2.1 0.1
time (msec) 15 10 31±1.0 31±1.3 32±2.3 -0.1 1.5
30 10 31±1.4 31±1.6 31±1.3 -0.6 0
b-wave Saline 10 113±19 116±17 100±17 3.3 -13.1
amplitude 5 10 106±34 101±25 98±17 -5.7 -8.5
( volt) 15 10 113±16 99±26 79±11 -14.2 -33.6
30 10 136±43 114±33 96±45 -22.7 -40.1 
30-Hz implicit Saline 10 32±1.7 32±3.9 31±1.9 -0.6 -0.9
flicker time 5 10 33±1.7 32±2.4 33±2.3 -0.2 0.1
response (msec) 15 10 32±1.2 32±2.8 36±1.8 0 3.8*
30 10 31±2.1 33±2.8 36±4.3 1.7 5.1*
amplitude Saline 10 31±7.2 40±2.9 28±6.6 8.3 -3.6
( volt) 5 10 21±5.5 23±6.2 23±7.4 2.6 2.0
15 10 26±4.4 31±8.8 19±5.4 5.1 -7.2
30 10 33±1.7 33±8.8 20±9.8 -0.1 -13.9
Table 1. Implicit times and amplitudes of the five standard responses after administering DA-8159 in rabbits
1, difference between baseline value and value obtained 1 hr after DA-8159 administration;  5, difference between baseline value and value obtained 5
hr after DA-8159 administration; *, statistically significant, p<0.05.Effect of DA-8159 on ERG 589
No abnormal light and electron microscopic findings were
observed in the DA-8159 treated groups. No abnormal find-
ings were observed either in the sensory retina, the photore-
ceptor rod and cone cells, the retinal pigment epithelial cells,
the Bruch’s membrane, or the choroidal vessels. An electron
microscopic examination showed the vascular endothelial cells
of the choroid exhibit well-preserved terminal bars connect-
ing the adjacent endothelial cells. 
DISCUSSION
ERG has established itself for many decades as a routine
diagnostic method in clinical ophthalmology. It is a summa-
tion of the electrical responses generated by the neural and
non-neuronal cells within the retina. However, it is necessary
to standardize the recording and interpreting protocols in
order to make it possible to compare the results elicited in
different institutions. In 1989 the ISCEV provided standard
ERG test procedures and five basic responses (9). The five
basic ERG responses are the rod response, the maximal rod
and cone response, the oscillatory potentials, the cone response,
and the 30-Hz flicker response. However, the standardization
is suitable for humans, but not for rabbits. The anatomical
and functional similarities of the rabbit retina have made it
a simulated model for an ophthalmic study, but the retinal
anatomy of the rabbit is slightly different from that of humans.
There are three types of cone cells in the human retina, but
only two, green cones and blue cones (10, 11), are present in
the rabbit retina. In addition, there is no standardized data
for the rabbit ERG, which makes it unadvisable to use human
ERG data in rabbits. Compared to the baseline values, a sta-
tistically significant difference was observed between each
group. Therefore, it is advisable to compare the time-depen-
dent ERG change in the given group with that of the control
group. In this study, the statistical significance of the time-
dependent ERG change was analyzed by comparing the data
from the test drug administrated group with that of the con-
trol group.
Luu et al. (12) studied the effect of sildenafil on the full-field
ERG, color vision and the subjective visual symptoms on
healthy volunteers. Two out of fourteen subjects who received
200 mg of sildenafil complained bluish vision. Those who
showed a depression in the ERG cone function made more
errors in the color vision test. In addition there was a correla-
tion between the ERG changes and the occurrence of the sub-
jective visual symptoms. They made a conclusion that 200 mg
sildenafil caused rather mild acute alterations in the cone and
rod function. Lee et al. (13) reported an alteration of ERG
after a single dose of 100 mg sildenafil ingestion. Similar ERG
changes were found in animal experiments. There was statis-
tically significant prolongation of the implicit time in the
30-Hz flicker response at doses of 15 mg/kg bw and 30 mg/
kg bw DA-8159 with a concurrent decrease in amplitude,
although this was statistically insignificant. Similar ERG ch-
anges were observed in the cone response at 30 mg/kg bw.
Such ERG changes were not observed at 5 mg/kg bw. Because
the 30-Hz flicker response or cone response represents the
photoreceptor cone function, its alteration may cause color
vision changes. These ERG changes are useful to explain the
pathogenesis of color vision alterations after PDE inhibitor
administration.
The mechanism of the ERG changes after PDE inhibitor
administration is still unclear. Theoretically a higher concen-
tration of a PDE inhibitor may cause an alteration in the pho-
totransduction process, resulting in the ERG changes. Behn
et al. (14) investigated the effect of sildenafil on the retina
in knockout mice, which were heterozygous for a mutation
causing an absence of the  subunit of rod PDE6. They found
that sildenafil significantly decreased the a-, and b-wave am-
plitudes in the heterozygous PDE6  subunit lacking mice.
Further decrease in both the a-, and b-wave amplitude were
observed with increasing sildenafil doses. The ERG decrease
was more pronounced in the heterozygous PDE6  subunit
lacking mice than in the wild mice containing normal PDE6.
This result shows that the sildenafil-induced ERG change is
not related to the PDE6 inhibition caused by sildenafil. How-
ever, they asserted that the heterozygous PDE6  subunit
knockout mutation probably leads to a decrease in the amount
of functional PDE6, creating an enhanced susceptibility to
the inhibitory effects of sildenafil. In contrast, Vobig et al. (15)
reported significant reductions in the a-, and b-wave ampli-
tudes 1 hr after administering sildenafil, and these effects
recovered to normal levels after 6 hr. The amplitude reduction
correlated well with the slidenafil plasma concentration, which
showed a peak 1 hr after administering the drug. Moreover,
Behn et al. (14) reported that sildenafil has a significant dose-
dependent inhibitory action on the retinal function. The reti-
nal inhibitory effect occurred with as little as twice the maxi-
mum equivalent dose recommended for humans. These results
indicate a close correlation between the sildenafil blood con-
centration and the ERG change. However, this study found
no significant ERG change at 5 mg/kg bw DA-8159, which
was 3.5 times higher-dose recommended for a 70 kg person.
In this animal study, no correlation between the DA-8159
blood concentration and ERG changes could be found. The
mean blood concentration at 1 hr after DA-8159 15 mg/kg
bw administration was as high as 2.2 times than that observed
5 hr after (0.031 g/mL vs. 0.014  g/mL, p<0.05), but the
Dose
(mg/kg)
No.
Time after DA-8159 administration
1 hr 5 hr
5 5 not detected not detected
15 5 0.031±0.021 0.014±0.001
30 5 0.392±0.112 0.010±0.004
Table 2. Mean blood concentrations ( g/mL) after administra-
tion in rabbits 590 H.K. Cho, K.K. Kang, G.J. Ahn, et al.
ERG amplitude changes were the opposite. There was a statis-
tically significant ERG cone response change 5 hr after admin-
istering the test drug, not after 1 hr. As provided by manufac-
turer, the Tmax of blood DA-1859 is approximately 60 min
after ingestion. If the ERG changes are due to the PDE6 inhi-
bition effect of DA-8159, the changes will peak around 1 hr
after administration, not 5 hr after. This suggests no signifi-
cant correlation between the DA-8159 blood concentration
and the ERG changes. Schneider et al. (16) reported a change
in the ERG response related to the dose of the PDE inhibitor
in cats. The phosphodiesterase inhibitor increased the rod b-
wave amplitude at low concentrations, but diminished the
rod b-wave amplitude at high concentrations. In view of the
results, it is possible that there is a correlation between blood
concentration of PDE inhibitor and the ERG change at rel-
atively high doses, positively or negatively. However, there
is some uncertainty in the correlation between the blood
DA1859 concentration and the ERG change.
In conclusion, there were no significant ERG changes after
administering 5 mg/kg bw DA-8159. However, at 15 mg
or 30 mg/kg bw, a statistically significant prolongation of
the 30-Hz flicker implicit time was observed 5 hr after the
test drug administration. Furthermore, there was a b-wave
amplitude decrease in the cone response at 15 mg or 30 mg/
kg bw, although this was statistically insignificant. Otherwise,
no remarkable ERG changes were observed in the rod, the
maximal, and the oscillatory potentials. There was no corre-
lation between the blood DA-8159 concentration and the
ERG change. In light and electron microscopic examinations,
there were no histological changes after DA-8159 adminis-
tration at any dose or at any time. These data suggest DA-
8159 has a minimal effect on ERG changes in rabbits, but
further evaluation of the effects of DA-8159 on visual func-
tions in human must be followed. 
REFERENCES
1. Oh TY, Kang KK, Ahn BO, Kim WB. Erectogenic effect of the selec-
tive phosphodiesterase type 5 inhibitor, DA-8159. Arch Pharm Res
2000; 23: 471-6.
2. Gabrieli CB, Regine F, Vingolo EM, Rispoli E, Fabbri A, Isidori A.
Subjective visual halo after sildenafil administration. Ophthalmology
2001; 108: 877-81.
3. Donahue SP, Taylor RJ. Pupil-sparing third nerve palsy associated
with sildenafil citrate (Viagra). Am J Ophthalmol 1998; 126: 476-7.
4. Egan RA, Pomeranz HD, Smith KH, Hart WM Jr. Sildenafil associ-
ated anterior ischemic optic neuropathy. Arch Ophthalmol 2000; 118:
2-25.
5. Pomeranz HD, Smith KH, Hart WM, Egan RA. Sildenafil-associat-
ed nonarteritic anterior ischemic optic neuropathy. Ophthalmology
2002; 109: 584-7.
6. Gherezghiher T, Okubo H, Koss MC. Choroidal and ciliary blood
flow analysis: application of laser doppler flowmetry in experimen-
tal animals. Exp Eye Res 1991; 53: 151-6.
7. Riva CE. Basic principles of laser doppler flowmetry and application
to the ocular circulation. Int Ophthalmol 2001; 23: 183-9.
8. Cunningham AV, Smith KH. Anterior ischemic optic neuropathy
associated with viagra. J Neuroophthalmol 2001; 21: 22-5.
9. International Standardization Committee: Standard for clinical elec-
troretinography. Arch Ophthalmol 1989; 107: 816-9.
10. Famiglietti EV, Sharpe SJ. Regional topography of rod and immuno-
cytochemically characterized blue and green cone photoreceptors
in rabbit retina. Vis Neurosci 1995; 12: 1151-75.
11. Vardi N, Duvoisin R, Wu G, Sterling P. Localization of mGluR6 to
dendrites of ON bipolar cells in primate retina. J Comp Neurol 2000;
423: 402-12.
12. Luu JK, Chappelow AV, McCulley TJ, Marmor MF. Acute effects of
sildenafil on the electroretinogram and multifocal electroretinogram.
Am J Ophthalmol 2001; 132: 388-94.
13. Lee G, Kim S, Park Y. The changes on electroretinogram following
sildenafil ingestion. J Korean Ophthalmol Soc 2003; 44: 2804-10. 
14. Behn D, Potter MJ. Sildenafil-mediated reduction on retinal function
in heterozygous mice lacking the  -subunit of phosphodiesterase.
Invest Ophthalmol Vis Sci 2001; 42: 523-7.
15. Vobig MA, Klotz T, Staak M, Bartz-Schmidt KU, Engelmann U, Wal-
ter P. Retinal side-effects of sildenafil. Lancet 1999; 353: 375.
16. Schneider T, Zrenner E. The influence of phosphodiesterase inhibitors
on ERG and optic nerve response of the cat. Invest Ophthalmol Vis
Sci 1986; 27: 1395-403. 